A retrospective multicenter observational study to evaluate whether drug survival is influenced by availability of treatment options and by factors such as gender, psoriatic arthritis, or previous biologic treatment
Latest Information Update: 16 Dec 2020
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Ixekizumab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis; Psoriasis
- Focus Therapeutic Use
- 16 Dec 2020 New trial record
- 01 Dec 2020 Results published in the British Journal of Dermatology